Tecentriq 840 mg/14mL
Tecentriq 840 mg/14mL is a prescription medicine used to treat certain types of cancer. It contains atezolizumab, an immunotherapy medicine that works with your immune system to fight cancer. It is a biological drug that currently has no equivalent or biosimilar.
Tecentriq is a medicine used in the treatment of cancer that contains the active ingredient atezolizumab. It is in a group of drugs called monoclonal antibodies. A monoclonal antibody is a type of protein designed to recognize and bind to a specific target substance in the body. This antibody may help your immune system fight cancer.
Atezolizumab was produced using the Chinese hamster ovary (CHO) cell line.
Tecentriq is used in adults with the following symptoms. It is used in combination with chemotherapy (nab-paclitaxel) to treat a type of cancer called Triple Negative Breast Cancer (UNBC):
- Your doctor has tested your cancer and found that you have high levels of a protein called programmed death ligand (PD-L1) in your body.
- The cancer has spread to other parts of the body. and when not treated with anti-cancer drugs (chemotherapy).
It must be 12 months since the adjuvant therapy you received for early-stage breast cancer has been completed.
Tecentriq works by binding to a protein in your body called "PD-L1". This protein causes the body's immune system to not work well enough; It prevents immune cells from attacking cancer cells. TECENTRIQ, It helps your immune system fight against cancer by binding to this protein.
Tecentriq 840 mg/14mL You can contact us to find out the price:Contact for detailed information Prospectus